当前位置:首页 - 行情中心 - 灵康药业(603669) - 财务分析 - 利润表

灵康药业

(603669)

  

流通市值:37.26亿  总市值:37.26亿
流通股本:7.12亿   总股本:7.12亿

利润表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、营业总收入360,181,521.33257,457,947.3786,535,882.34322,483,887.6
  营业收入360,181,521.33257,457,947.3786,535,882.34322,483,887.6
二、营业总成本329,286,081.99231,452,857.7783,969,840.24490,562,003.63
  营业成本186,199,890.57151,094,269.561,573,676.62181,515,762.37
  税金及附加3,121,944.81,676,830.18949,021.724,189,910.55
  销售费用74,862,373.0134,625,537.494,157,824.12154,808,685.74
  管理费用42,457,927.9128,860,958.499,780,399.9174,612,084.15
  研发费用6,037,133.554,271,016.922,055,959.4612,701,213.38
  财务费用16,606,812.1510,924,245.195,452,958.4162,734,347.44
  其中:利息费用16,641,216.110,949,533.785,461,824.8921,197,524.07
  其中:利息收入72,721.5942,664.1120,425.75237,874.25
三、其他经营收益
  加:公允价值变动收益-963,751.33-4,012,230.841,495,886.93-570,782.06
  加:投资收益-359,884.75-505,778.54-132,297.56-2,407,842.88
  资产处置收益82,662.0682,662.0682,662.063,533,141.93
  资产减值损失(新)-135,442.88-87,913.95327,110.24-41,449,843.73
  信用减值损失(新)-6,381,942.12-6,655,894.68-1,550,910.24914,989.13
  其他收益9,496,199.397,021,052.06762,747.0412,084,600.62
四、营业利润32,633,279.7121,846,985.713,551,240.57-195,973,853.02
  加:营业外收入4,352.15535.250.094,204,002.34
  减:营业外支出397,040.37398,321.74397,335.131,744,582
五、利润总额32,240,591.4921,449,199.223,153,905.53-193,514,432.68
  减:所得税费用413,989.28336,505.88198,000.01-275,081.29
六、净利润31,826,602.2121,112,693.342,955,905.52-193,239,351.39
(一)按经营持续性分类
  持续经营净利润31,826,602.2121,112,693.342,955,905.52-193,239,351.39
(二)按所有权归属分类
  归属于母公司股东的净利润31,826,602.2121,112,693.342,955,905.52-193,239,351.39
  扣除非经常损益后的净利润23,605,942.2418,420,758.481,013,706.46-170,095,301.28
七、每股收益
  (一)基本每股收益0.040.030-0.27
  (二)稀释每股收益0.040.030-0.27
八、其他综合收益---2,004,742.18
  归属于母公司股东的其他综合收益---2,004,742.18
九、综合收益总额31,826,602.2121,112,693.342,955,905.52-191,234,609.21
  归属于母公司股东的综合收益总额31,826,602.2121,112,693.342,955,905.52-191,234,609.21
公告日期2026-10-242026-08-152026-04-292026-04-29
审计意见(境内)标准无保留意见
TOP↑